St. Louis, MO, United States of America

Ashok Gopal Chaudhary

This inventor holds 3 USPTO granted patents. Top assignee: Virginia Tech Intellectual Properties Inc.. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashok Gopal Chaudhary. Retrieved from https://idiyas.com/inventor/ashok-gopal-chaudhary

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Ashok Gopal Chaudhary

Introduction

Ashok Gopal Chaudhary is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of taxol derivatives. With a total of 3 patents, his work has the potential to impact cancer treatment and related therapies.

Latest Patents

Chaudhary's latest patents include the invention of 2-debenzoyl-2-acyl taxol derivatives and methods for making the same. This invention relates to compounds that have a specific general formula, which includes various alkyl and aryl groups. The compounds are designed to enhance the efficacy of taxol, a well-known chemotherapeutic agent.

Career Highlights

Chaudhary is associated with Virginia Tech Intellectual Properties, Inc., where he continues to innovate and develop new pharmaceutical compounds. His work is characterized by a strong focus on improving existing treatments and creating new therapeutic options.

Collaborations

He has collaborated with notable colleagues such as David G Kingston and Milind Moreshwar Gharpure, contributing to a rich environment of research and development.

Conclusion

Ashok Gopal Chaudhary's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments that could benefit many patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…